IMSC.ob 0.43 Announces Another Order:
Implant Sciences Announces $250,000 Order from Major Aviation Security Customer in Asia
Follow-on order for QS-H150 Portable Explosives Detector
March 30, 2010, 9:00 am
WILMINGTON, Ma.--(BUSINESS WIRE)--Implant Sciences Corporation (OTCBB: IMSC - News), a high technology supplier of systems and sensors for homeland security and defense markets, has been awarded a follow-on order from a major international security agency for its QS-H150 Portable Explosives Detectors to be used at aviation security checkpoints. The order is valued at more than $250,000 and is a follow-on to an order received in 2009 for a similar quantity.
Glenn D. Bolduc, CEO, commented, “Implant Sciences is proud of this repeat business which represents growing success in aviation security markets.” Mr. Bolduc continued, “The Company commends the efforts of our channel partners for the work they have done in securing this business and satisfying a valuable customer.”
About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. For further details on the Company and its products, please visit the Company's website at cts.businesswire.com.
Safe Harbor Statement
This press release may contain certain “forward-looking statements,” as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management’s current expectations and are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the U.S. government or by other law enforcement agencies or commercial consumers of security products; liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; our business is subject to intense competition and rapid technological change; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.
Contact:
Implant Sciences CorporationGlenn Bolduc, President and CEO978-752-1700gbolduc@implantsciences.comorInvestor Contact:Aimee Boutcher973-239-2878aboutcher@aol.com |
